SE396011B - PROCEDURE FOR THE PREPARATION OF A MAINLY CLEAR, STERILE AUTOMATIC SOLUTION OF 1,3-BIS (2-CARBOXYCHROMONE-5-YLOXY) -PROPAN-2-OL OR A PHARMACEUTICAL ACCEPTABLE SALT thereof - Google Patents

PROCEDURE FOR THE PREPARATION OF A MAINLY CLEAR, STERILE AUTOMATIC SOLUTION OF 1,3-BIS (2-CARBOXYCHROMONE-5-YLOXY) -PROPAN-2-OL OR A PHARMACEUTICAL ACCEPTABLE SALT thereof

Info

Publication number
SE396011B
SE396011B SE7206151A SE615172A SE396011B SE 396011 B SE396011 B SE 396011B SE 7206151 A SE7206151 A SE 7206151A SE 615172 A SE615172 A SE 615172A SE 396011 B SE396011 B SE 396011B
Authority
SE
Sweden
Prior art keywords
carboxychromone
yloxy
propan
bis
procedure
Prior art date
Application number
SE7206151A
Other languages
Swedish (sv)
Inventor
N A Stevenson
G Wardell
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26250625&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE396011(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of SE396011B publication Critical patent/SE396011B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Otolaryngology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7206151A 1971-05-12 1972-05-09 PROCEDURE FOR THE PREPARATION OF A MAINLY CLEAR, STERILE AUTOMATIC SOLUTION OF 1,3-BIS (2-CARBOXYCHROMONE-5-YLOXY) -PROPAN-2-OL OR A PHARMACEUTICAL ACCEPTABLE SALT thereof SE396011B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1452971 1971-05-12
GB5716971A GB1399834A (en) 1971-05-12 1971-12-09 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
SE396011B true SE396011B (en) 1977-09-05

Family

ID=26250625

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7206151A SE396011B (en) 1971-05-12 1972-05-09 PROCEDURE FOR THE PREPARATION OF A MAINLY CLEAR, STERILE AUTOMATIC SOLUTION OF 1,3-BIS (2-CARBOXYCHROMONE-5-YLOXY) -PROPAN-2-OL OR A PHARMACEUTICAL ACCEPTABLE SALT thereof

Country Status (15)

Country Link
JP (1) JPS5425082B1 (en)
AU (1) AU465305B2 (en)
BE (1) BE782981A (en)
CA (1) CA1000201A (en)
CY (1) CY955A (en)
DE (2) DE2266025A1 (en)
DK (1) DK131324B (en)
FR (1) FR2139872B1 (en)
GB (1) GB1399834A (en)
HK (1) HK69276A (en)
IE (1) IE36337B1 (en)
IL (1) IL39286A (en)
MY (1) MY7700080A (en)
NL (1) NL177386B (en)
SE (1) SE396011B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2230358A2 (en) * 1973-05-25 1974-12-20 Fisons Ltd Cromoglycate contg. solns. - contg. a second therapeutically active cpd. e.g. an antihistamine
DE2634908A1 (en) * 1974-11-09 1977-04-14 Fisons Ltd Bis carboxy-chromonyl-oxy alkane compsn.
DE3700379A1 (en) * 1987-01-08 1988-07-21 Mann Gerhard Chem Pharm Fab PRESERVED EYE DROPS WITH A CROMOGLICIC ACID CONTENT
DE68915203T2 (en) * 1988-03-22 1994-09-22 Fisons Plc, Ipswich, Suffolk Pharmaceutical blends.
GB8819490D0 (en) * 1988-08-16 1988-09-21 Fisons Plc Pharmaceutical devices
AT410894B (en) * 1988-03-22 2003-08-25 Fisons Plc Aerosol dispensers contg. soln. of inhalation medicament
FR2649890A1 (en) * 1988-03-22 1991-01-25 Fisons Plc Pharmaceutical compositions
US6004949A (en) * 1995-12-27 1999-12-21 Showa Yakuhin Kako Co., Ltd. Aqueous composition containing cromoglycic acid
DE19614823A1 (en) 1996-04-15 1997-10-16 Mann Gerhard Chem Pharm Fab Ophthalmic composition with prolonged retention time on the eye
EP0938896A1 (en) * 1998-01-15 1999-09-01 Novartis AG Autoclavable pharmaceutical compositions containing a chelating agent
JP5785353B2 (en) * 2004-02-27 2015-09-30 大正製薬株式会社 Ophthalmic agent
JP5992293B2 (en) * 2012-10-31 2016-09-14 大正製薬株式会社 Ophthalmic agent
PL426472A1 (en) * 2018-07-27 2020-02-10 Kalbarczyk Grzegorz Arkona Laboratorium Farmakologii Stomatologicznej Medical application of domifen bromide and a composition for the treatment of inflammation in the mouth

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1144905A (en) * 1965-03-25 1969-03-12 Fisons Pharmaceuticals Ltd Substituted bis-(2-carboxy-chromonyl-oxy) derivatives and preparation and pharmaceutical compositions thereof
GB1190194A (en) * 1966-07-05 1970-04-29 Fisons Pharmaceuticals Ltd Bis-Phenoxy Compounds and Chromanone and Chromone Derivatives

Also Published As

Publication number Publication date
NL177386B (en) 1985-04-16
MY7700080A (en) 1977-12-31
BE782981A (en) 1972-11-03
IL39286A (en) 1975-02-10
FR2139872B1 (en) 1975-10-31
DK131324C (en) 1975-11-24
FR2139872A1 (en) 1973-01-12
DE2223237C2 (en) 1985-01-17
DE2223237A1 (en) 1972-12-14
HK69276A (en) 1976-11-12
AU465305B2 (en) 1975-09-25
JPS5425082B1 (en) 1979-08-25
DE2266025A1 (en) 1985-03-07
IE36337L (en) 1972-11-12
DK131324B (en) 1975-06-30
IL39286A0 (en) 1972-06-28
CA1000201A (en) 1976-11-23
AU4208072A (en) 1973-11-15
GB1399834A (en) 1975-07-02
NL7206251A (en) 1972-11-14
IE36337B1 (en) 1976-10-13
CY955A (en) 1978-12-22

Similar Documents

Publication Publication Date Title
SE402709B (en) PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF HYPERCOLESTEROLEMIA, CONTAINING β-CHLOROPHENOXIISOSMOROIC ACID OR CERTAIN ESTRARS OR SALTS THEREOF
AT327390B (en) PROCESS FOR THE MANUFACTURING OF SOLID, SLOW RELEASE OF THE ACTIVE INGREDIENT, PHARMACEUTICAL PREPARATIONS
DK149895C (en) PROCEDURE FOR THE PREPARATION OF ALFA-AMINOACYLPROLYL-NG-CARBOXY ARGINALDEHYDE DERIVATIVES OR PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS.
SE396011B (en) PROCEDURE FOR THE PREPARATION OF A MAINLY CLEAR, STERILE AUTOMATIC SOLUTION OF 1,3-BIS (2-CARBOXYCHROMONE-5-YLOXY) -PROPAN-2-OL OR A PHARMACEUTICAL ACCEPTABLE SALT thereof
SE405121B (en) PROCEDURE FOR THE PREPARATION OF 2- (HETEROARYL-METHYL) -5-9BETA-DIALKYL-6,7-BENZOMORPHANES OR THEIR ACID ADDITIONAL SALTS
OA04433A (en) Process for the preparation of substituted diphenyl ethers.
DK125021B (en) Analogous process for the preparation of 1,2,3,4-tetrahydro-4-phenyl-isoquinoline derivatives or acid addition salts thereof or the corresponding optically active compounds.
SE419033B (en) PROCEDURE FOR THE PREPARATION OF A VETERINARY MEDICINE, ANTIBACTERIAL PREPARATION, INCLUDING BLA N '- (4,5-DIMETHYL-3-ISOXAZOLYL) -SULPHANILAMIDE
DK133899B (en) Analogous process for the preparation of benzofuran derivatives or pharmaceutically acceptable acid addition salts thereof.
SE422214B (en) PROCEDURE FOR THE PREPARATION OF ANTIBIOTIC A 2041 DERIVATIVE OR PHYSIOLOGICALLY ACCEPTABLE CATIONIC SALTS THEREOF
DK136722B (en) Analogous process for the preparation of oxazolidinone (2) derivatives or acid addition salts thereof.
DK128779B (en) Analogous process for the preparation of 2-arylamino-imidazoline- (2)'s or acid addition salts thereof.
SE431216B (en) PROCEDURE FOR THE PREPARATION OF 1N- (ALFA-HYDROXY-OMEGA-AMINO-ALKANOYL) -6 721N-METHYL-3 721, 4 721-DIDEOXICANAMYCINE B OR PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS.
SE396074B (en) METHODS OF PREPARING CERTAIN DETAILED ALKANOLAMINE DERIVATIVES OR PHYSIOLOGICALLY TABLE ACID ADDITIONAL SALTS THEREOF
DK135574B (en) Process for the preparation of benzylamine derivatives or physiologically useful acid addition salts thereof.
NO144488C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVITIES 8,12-DIISOPROSTANIC ACID DERIVATIVES
SE7700792L (en) PROCEDURE FOR THE PREPARATION OF N, N'-DICHLOR-ISOPHTHALIC ACID
SE403616B (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF DIBENSOXIRENAZE PINDER OR PHARMACEUTICAL ACCEPTABLE SALTS THEREOF
AR204615A1 (en) PROCEDURE FOR THE PREPARATION OF DERIVATIVES OF 1,3-BIS- (HYDANTOINYL-3 ') - PROPAN-2-OL
DK134436C (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF S (IV) -BENZO-1,2,4-THIADIAZINES OR ACID ADDITIONAL SALTS THEREOF
SE403773B (en) PROCEDURE FOR THE PREPARATION OF CERTAIN ALFA-AMINOALKYL-4-HYDROXY-3 (ALKYLSULPHONYLMethyl) BENZYL ALCOHOLS OR PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALTS THEREOF
DK139943B (en) Process for the preparation of triazolo (4,3a) (1,4) benzodiazepine-5N-oxide derivatives or acid addition salts thereof.
DK131470B (en) Analogous process for the preparation of racemic or optically active thiazolino-pyrimidin-5-one derivatives or acid addition salts thereof.
IT998441B (en) PROCEDURE FOR THE PREPARATION OF 3.3 TIOBIS 2 METOSSI I AZABEN ZANTRONE
DK136152B (en) Analogous process for the preparation of 1-aminomethyl derivatives of 2,2-diarylclopropanes or acid addition salts thereof.